These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22522007)

  • 1. Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability.
    Scherman MS; North EJ; Jones V; Hess TN; Grzegorzewicz AE; Kasagami T; Kim IH; Merzlikin O; Lenaerts AJ; Lee RE; Jackson M; Morisseau C; McNeil MR
    Bioorg Med Chem; 2012 May; 20(10):3255-62. PubMed ID: 22522007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties.
    North EJ; Scherman MS; Bruhn DF; Scarborough JS; Maddox MM; Jones V; Grzegorzewicz A; Yang L; Hess T; Morisseau C; Jackson M; McNeil MR; Lee RE
    Bioorg Med Chem; 2013 May; 21(9):2587-99. PubMed ID: 23498915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure-activity relationship of urea derivatives as anti-tuberculosis agents.
    Brown JR; North EJ; Hurdle JG; Morisseau C; Scarborough JS; Sun D; Korduláková J; Scherman MS; Jones V; Grzegorzewicz A; Crew RM; Jackson M; McNeil MR; Lee RE
    Bioorg Med Chem; 2011 Sep; 19(18):5585-95. PubMed ID: 21840723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-QSAR Selectivity Analysis of 1-Adamantyl-3-Heteroaryl Urea Analogs as Potent Inhibitors of Mycobacterium tuberculosis.
    Wadhwa P; Bagchi S; Sharma A
    Curr Comput Aided Drug Des; 2015; 11(2):164-83. PubMed ID: 26234390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.
    Li W; Upadhyay A; Fontes FL; North EJ; Wang Y; Crans DC; Grzegorzewicz AE; Jones V; Franzblau SG; Lee RE; Crick DC; Jackson M
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6413-23. PubMed ID: 25136022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy.
    Kale RR; Kale MG; Waterson D; Raichurkar A; Hameed SP; Manjunatha MR; Kishore Reddy BK; Malolanarasimhan K; Shinde V; Koushik K; Jena LK; Menasinakai S; Humnabadkar V; Madhavapeddi P; Basavarajappa H; Sharma S; Nandishaiah R; Mahesh Kumar KN; Ganguly S; Ahuja V; Gaonkar S; Naveen Kumar CN; Ogg D; Boriack-Sjodin PA; Sambandamurthy VK; de Sousa SM; Ghorpade SR
    Bioorg Med Chem Lett; 2014 Feb; 24(3):870-9. PubMed ID: 24405701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A piperidinol-containing molecule is active against
    Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
    J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
    Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
    Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane.
    Grzegorzewicz AE; Pham H; Gundi VA; Scherman MS; North EJ; Hess T; Jones V; Gruppo V; Born SE; Korduláková J; Chavadi SS; Morisseau C; Lenaerts AJ; Lee RE; McNeil MR; Jackson M
    Nat Chem Biol; 2012 Feb; 8(4):334-41. PubMed ID: 22344175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
    Nikonenko BV; Kornienko A; Majorov K; Ivanov P; Kondratieva T; Korotetskaya M; Apt AS; Salina E; Velezheva V
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds
    Li W; Sanchez-Hidalgo A; Jones V; de Moura VC; North EJ; Jackson M
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties.
    Kim IH; Tsai HJ; Nishi K; Kasagami T; Morisseau C; Hammock BD
    J Med Chem; 2007 Oct; 50(21):5217-26. PubMed ID: 17894481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity.
    Dobrikov GM; Valcheva V; Nikolova Y; Ugrinova I; Pasheva E; Dimitrov V
    Eur J Med Chem; 2013 May; 63():468-73. PubMed ID: 23524112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain.
    Rose TE; Morisseau C; Liu JY; Inceoglu B; Jones PD; Sanborn JR; Hammock BD
    J Med Chem; 2010 Oct; 53(19):7067-75. PubMed ID: 20812725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.
    Kale MG; Raichurkar A; P SH; Waterson D; McKinney D; Manjunatha MR; Kranthi U; Koushik K; Jena Lk; Shinde V; Rudrapatna S; Barde S; Humnabadkar V; Madhavapeddi P; Basavarajappa H; Ghosh A; Ramya VK; Guptha S; Sharma S; Vachaspati P; Kumar KN; Giridhar J; Reddy J; Panduga V; Ganguly S; Ahuja V; Gaonkar S; Kumar CN; Ogg D; Tucker JA; Boriack-Sjodin PA; de Sousa SM; Sambandamurthy VK; Ghorpade SR
    J Med Chem; 2013 Nov; 56(21):8834-48. PubMed ID: 24088190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial Epoxide Hydrolase EphD Is Inhibited by Urea and Thiourea Derivatives.
    Madacki J; Kopál M; Jackson M; Korduláková J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.